Swinging $CLPS, $AKTX, $CAPR
$CLPS had a nice move. Scaled out some to free up some cash and deploy elsewhere. Still like $CLPS swing for a possible multi-week move but had to book some gains and reduce exposure to the ticker. If it re-traces to low $3s, and I’ve some cash available, I’ll be all over it. Plan to continue holding a core.
Used some of the proceeds to enter two new swings:
$AKTX buying right at the support at $1.75 ish level. Co has guided for pivotal trial start news which may make the stock pop. Will look to sell into it. If chart continues to degrade, I’ll cut it off
$CAPR bought new position in this again. Like I mentioned in the last post when I exited the previous trade, took some time to think through the most recent raise and let the market digest the news. A couple things I still like about it perhaps going into January 2020
Chart still beat down so downside risk appears small
Co now well funded so no immediate risk of dilution
Most recent raise was largely funded by a single healthcare focused tute so I’m curious to find out who they are when 13G comes out. Might get a pop if the tute is a well respected name. Several of the insiders also participated in the raise so that is bullish to me
Co mentioned in sec filings that the raise was predominantly to fund the exosomes program. Personally think they’re sitting on some exosomes related data that once released could make the stock pop
Lastly, it also implies that co is still likely negotiating with FDA on trial design for CAP 1002 program for DMD which they’re also looking for a partner on. Once the trial design gets finalized, partnership opportunity becomes more real to come to fruition. The fact that they raised only $5M which is nowhere near what they need to fund the DMD trial makes me a bit more bullish on the partnership opportunity
In summary, more reasons to be in the stock right now than not. We shall see how it pans out.